Archive for the ‘ExL Events News’ Category
Meet the Chairpersons of the 13th Partnering With ACOs & IDNs Summit and 5th Payer Partnership Forum
Meet the three chairpersons of the 13th Partnering With ACOs & IDNs Summit and 5th Payer Partnership Forum. This year’s conferences will be guided by these three industry leaders to teach attendees to strategically increase collaborations with ACOs, IDNs, and Payers through tactical partnerships. These three experts, along with our incredible speaking faculty, will share their experiences and guide attendees through two days of detailed sessions, insightful panels, collaborative workshops, and dynamic discussions.
CLICK HERE to register for our ACOs/IDNs Summit and HERE for our Payer Partnership Forum, both on June 10–11 in Boston, MA.
The 13th Partnering With ACOs & IDNs Summit is taking place on June 10–11 in Boston and our Early Bird discount expires this Friday, May 3, 2019. This is a one-of-a-kind event that you can’t afford to miss! More than ever, this year’s Summit offers a unique opportunity of valuable face-to-face time with key executives from various ACOs and IDNs from around the nation that total over 3.5 million patients served in 2018.
Click Here to Register!
In combination with the 5th Payer Partnership Forum, these joint sessions with 100+ attendees feature representatives from Atena, Blue Cross Blue Shield, Johns Hopkins,…
I invite you to view the brochure for the 2019 Drug Pricing and Reimbursement Stakeholder Summit, taking place on July 15–16 in Philadelphia!
With unpredictable changes occurring in the drug pricing transparency landscape, it is imperative to stay ahead of legislation and trends, thus maintaining a competitive edge within the industry.
Through panels, case studies, and focused presentations, this conference will showcase how key stakeholders surrounding drug pricing matters are initiating change to accommodate for drug pricing shifts.
Download the Brochure!
EXPLORE CHANGES TO THE POLICY LANDSCAPE THROUGH AN OVERVIEW OF THE MOST PREVALENT STATE TRANSPARENCY…
Do not miss the opportunity to hear from over 30 life science, healthcare, and tech professionals at the AI Innovations for Life Science and Healthcare Summit East, taking place June 13–14 in Philadelphia, as we elevate clinical trial operations, healthcare outcomes, and supply chain implementation through AI.
Click HERE to Register!
Artificial intelligence is recognized as a powerful tool for enhancing research and development of novel therapeutics. Machine learning and model training can, too, efficiently analyze large volumes of data for deeper insights to inform drug and device development. If AI or machine learning can improve the success or speed…
We invite you to join industry experts at our 15th Public Relations Communications Summit, taking place on July 22–23 in Plainsboro, NJ. This is the ONLY conference dedicated to providing life science communicators with industry updates and best practices for successful communication strategies during today’s complex healthcare environment.
Download the Brochure Now!
The Summit is designed to provide you with in-depth, tactical presentations that present you with a road map to implement similar programming at your organization and insights into some of the leading healthcare trends impacting the industry today and in the future.
Implement the requirements necessary to…
Join pharmaceutical, biotechnology, and medical device industry meeting professionals to discuss, engage, and share challenges and best practices to optimize medical meeting management. After 15 years of success in the US, ExL Events brings their well-known Pharma Meeting Pros Summit to Europe on 4–5 June in Barcelona.
Register by this Friday 19 April for maximum savings. Click here to register now!
Download the brochure now!
Session topics include:
Top Compliance Challenges
Global Meeting Management
Contracting And Negotiating
Strategic Meeting Management
Global Communication Optimisation
This interactive event…
ExL is excited to announce that the 15th Public Relations & Communications Summit is taking place on July 22–23 at Novo Nordisk in Plainsboro, NJ. This event is the ONLY conference dedicated to providing life science communicators with industry updates and best practices for successful communications strategies during today’s complex healthcare environment.
Don’t miss out on the opportunity to network with your peers and other industry professionals.
This year attendees can expect to:
Understand the internal and external structures and roles within an organization
Network with all levels from junior, mid-level, and senior
Broaden views beyond the audience and hear…
As the chairperson of the 5th Payer Partnership Forum, I invite you to join me in Boston on June 10–11, 2019, for this innovative and collaborative event. This year’s conference will arm attendees with vital information on the most important topics in managed care and pharmaceutical delivery that will foster partnerships with payers in a venue that will provide valuable networking opportunities with representatives from across the healthcare value chain. The 2019 Forum creates mutually beneficial partnerships through collaborative discussions centered on value-based engagements, specialty pharmacy, and patient adherence.
To view the full program, click here.
As chairperson, I am excited to…
ExL Events proudly extends their well-known Pharma Meeting Pros Summit to Europe. Participate in a research-based, educational programme on meeting and event planning in the life science industries, offering an intimate and interactive setting, ideal for networking and learning.
Join your peers on 4–5 June in Barcelona.
Click here to register!
Samme Allen, MC-Facilitator-Moderator, SAMME ALLEN LTD
Download the brochure now!
Featured Session Topics
GLOBAL MEETING MANAGEMENT
Overcome Common Challenges to Global Meeting Optimisation and Best Practices for Success
TOP COMPLIANCE CHALLENGES
Evaluate the Top Compliance…
…Sodium Acetate, or 11-C Acetate, an unapproved drug. OPDP wrote their first warning letter of the year to an investigational drug at the Phoenix Molecular Imaging Center. They’ve claimed that 11-C, which acts as a PET scan for detecting recurrent prostate cancer, is misbranded.
As there is a grey area for Phoenix answering various, everyday questions of “what is available,” “how do they compare,” and “what are the parameters for successful imaging,” the FDA claims that their webpage is promoting the investigational drug as safe and effective while still going under investigation.
You can read more on this particular case
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs